To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 510 participants.
Also called NCT07619833
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 510 participants
- Registry
-
NCT07619833
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07619833. Randomized; quadruple masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2027-11 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus
- Condition
- T2DM (Type 2 Diabetes Mellitus)
- Intervention (Drug)
- DWP16001
- Intervention (Drug)
- DWC202518
- Intervention (Drug)
- Placebo of DWP16001
- Intervention (Drug)
- Placebo of DWC202518
- Lead sponsor
- Daewoong Pharmaceutical Co. LTD.
Record details
- Record id
cardio:ct-nct07619833- Content hash
ded4977035eb4f904ba8865b24f12f34809bb2c06299af736303dd53e3468e7c